First human test: can a new cholesterol pill work safely in damaged kidneys?
NCT ID NCT07322016
Summary
This is an early safety study to see how a new cholesterol-lowering drug (HRS-1301) is processed by the body in people with mild, moderate, or severe kidney problems. Researchers will compare the drug's levels in the blood and urine of 36 participants with kidney issues to those of healthy volunteers. The main goal is to gather information to help determine safe and effective doses for future patients who have both high cholesterol and reduced kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.